VentriPoint Diagnostics Ltd.
VPTDF
$0.07
$0.00-4.64%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 84.36% | 25.27% | 83.71% | 258.56% | 92.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 84.36% | 25.27% | 83.71% | 258.56% | 92.54% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 84.36% | 25.27% | 102.93% | 321.91% | 123.40% |
| SG&A Expenses | -20.01% | -19.81% | -6.98% | -2.21% | -0.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.39% | -26.24% | -15.36% | -5.43% | -3.04% |
| Operating Income | 30.63% | 27.64% | 16.78% | 7.94% | 3.98% |
| Income Before Tax | 36.31% | 20.91% | 9.99% | 1.64% | -1.21% |
| Income Tax Expenses | 37.25% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.29% | 22.50% | 11.60% | 3.34% | 0.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.29% | 22.50% | 11.60% | 3.34% | 0.44% |
| EBIT | 30.63% | 27.64% | 16.78% | 7.94% | 3.98% |
| EBITDA | 30.64% | 27.63% | 16.73% | 7.87% | 3.91% |
| EPS Basic | 38.33% | 25.21% | 13.98% | 4.93% | 1.30% |
| Normalized Basic EPS | 25.00% | 22.30% | 11.56% | 2.88% | 0.00% |
| EPS Diluted | 38.33% | 25.21% | 13.98% | 4.93% | 1.30% |
| Normalized Diluted EPS | 25.00% | 22.30% | 11.56% | 2.88% | 0.00% |
| Average Basic Shares Outstanding | 4.56% | 4.24% | 2.78% | 1.68% | 0.87% |
| Average Diluted Shares Outstanding | 4.56% | 4.24% | 2.78% | 1.68% | 0.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |